Vardenafil Hydrochloride Tablet, Film Coated
Product Images NDC 71335-9688

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Vardenafil Hydrochloride (NDC 71335-9688). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula For Vardenafil Hydrochloride (Image 1)

Structural Formula For Vardenafil Hydrochloride (Image 1)
FDA Label Image

Figure 1: Placebo-subtracted Point Estimates (with 90% Ci) Of Mean Maximal Blood Pressure And Heart Rate Effects Of Pre-dosing With Vardenafil 20 mg At 24, 8, 4, And 1 Hour Before 0.4 mg Ntg Sublingually (Image 2)

Figure 1: Placebo-subtracted Point Estimates (with 90% Ci) Of Mean Maximal Blood Pressure And Heart Rate Effects Of Pre-dosing With Vardenafil 20 mg At 24, 8, 4, And 1 Hour Before 0.4 mg Ntg Sublingually (Image 2)
FDA Label Image

Figure 2: Mean Change From Baseline In Standing Systolic Blood Pressure (mmhg) Over 6 Hour Interval Following Simultaneous Or 6 Hr Separation Administration Of Vardenafil 5 mg Or Placebo With Stable Dose Tamsulosin 0.4 mg In Normotensive Bph Patients (study 1) (Image 3)

Figure 2: Mean Change From Baseline In Standing Systolic Blood Pressure (mmhg) Over 6 Hour Interval Following Simultaneous Or 6 Hr Separation Administration Of Vardenafil 5 mg Or Placebo With Stable Dose Tamsulosin 0.4 mg In Normotensive Bph Patients (study 1) (Image 3)
FDA Label Image

Figure 3: Mean Change From Baseline In Standing Systolic Blood Pressure (mmhg) Over 6 Hour Interval Following Simultaneous Or 6 Hr Separation Administration Of Vardenafil 5 mg Or Placebo With Stable Dose Terazosin (5 Or 10mg) In Normotensive Bph Patients (study 1) (Image 4)

Figure 3: Mean Change From Baseline In Standing Systolic Blood Pressure (mmhg) Over 6 Hour Interval Following Simultaneous Or 6 Hr Separation Administration Of Vardenafil 5 mg Or Placebo With Stable Dose Terazosin (5 Or 10mg) In Normotensive Bph Patients (study 1) (Image 4)
This appears to be a data table showing the mean change in blood pressure (measured in mmHg) over a certain amount of time (measured in hours). However, without additional context, it is difficult to determine the specific purpose or significance of this data.*
FDA Label Image

Figure 4: Mean Change From Baseline In Standing Systolic Blood Pressure (mmhg) Over 6 Hour Interval Following Simultaneous Administration Of Vardenafil 10 mg (stage 1), Vardenafil 20 mg (stage 2), Or Placebo With Stable Dose Tamsulosin 0.4 mg In Normotensive Bph Patients (study 2) (Image 5)

Figure 4: Mean Change From Baseline In Standing Systolic Blood Pressure (mmhg) Over 6 Hour Interval Following Simultaneous Administration Of Vardenafil 10 mg (stage 1), Vardenafil 20 mg (stage 2), Or Placebo With Stable Dose Tamsulosin 0.4 mg In Normotensive Bph Patients (study 2) (Image 5)
FDA Label Image

Figure 5: Mean Change From Base Line In Standing Systolic Blood Pressure (mmhg) Over 6 Hour Interval Following 4 Hr Separation Administration Of Vardenafil 5 mg (stage 1), Vardenafil 10 mg (stage 2) Or Placbo With Stable Dose Alfuzosin 10 mg I Bph Patients (study 3) (Image 6)

Figure 5: Mean Change From Base Line In Standing Systolic Blood Pressure (mmhg) Over 6 Hour Interval Following 4 Hr Separation Administration Of Vardenafil 5 mg (stage 1), Vardenafil 10 mg (stage 2) Or Placbo With Stable Dose Alfuzosin 10 mg I Bph Patients (study 3) (Image 6)
This text shows a chart or a graph representing the Mean Change (in millimeters of mercury or mmHg) of two groups: Placebo (Stage 1 and Stage 2) and Varder. The graph has two points plotted and connected by a line for each group, with one point on the axis labeled "-o-" and the other labeled "-e-". The numerical value 10 is also present.*
FDA Label Image

Figure 5: Man Change From Baseline In Standing Systolic Blood Pressure (mmhg) Over 6 Hour Interval Following Simultaneous Or 6 Hr Separation Administration Of Vardenafil 10 mg, Vardenafil 20 mg Or Placebo With Terazosin (10 mg) In Healthy Volunteers (Image 7)

Figure 5: Man Change From Baseline In Standing Systolic Blood Pressure (mmhg) Over 6 Hour Interval Following Simultaneous Or 6 Hr Separation Administration Of Vardenafil 10 mg, Vardenafil 20 mg Or Placebo With Terazosin (10 mg) In Healthy Volunteers (Image 7)
FDA Label Image

Figure 6: Mean Change From Baseline In Standing Systolic Blood Pressure (mmhg) Over 6 Hour Interval Following Simultaneous Or 6 Hr Separation Administration Of Vardenafil 10 mg, Vardenafil 20 mg Or Placebo With Tamsulosin (0.4 mg) In Healthy Volunteers (Image 8)

Figure 6: Mean Change From Baseline In Standing Systolic Blood Pressure (mmhg) Over 6 Hour Interval Following Simultaneous Or 6 Hr Separation Administration Of Vardenafil 10 mg, Vardenafil 20 mg Or Placebo With Tamsulosin (0.4 mg) In Healthy Volunteers (Image 8)
FDA Label Image

Figure 7: Plasma Vardenafil Concentration (mean Plus Or Minus Sd) Curve For A Single 20 mg Vardenafil Hydrochloride Dose (Image 9)

Figure 7: Plasma Vardenafil Concentration (mean Plus Or Minus Sd) Curve For A Single 20 mg Vardenafil Hydrochloride Dose (Image 9)
FDA Label Image

Label (Lbl713359688)

Label (Lbl713359688)
This text describes a drug called Vardenafil Hydrochloride. Each tablet contains 20 mg of Vardenafil HCI. It should be kept away from children and stored at 20° to 25° C (68° to 77° F), with permissible excursions from 15° to 30° C (59° to 86° F). The drug should be dispensed in a tight container using a child-resistant closure. The pharmaceutical company involved is Bryant Ranch Prepack, Inc. The drug is available in 30-tablet packaging with the NDC code 71335-9688-1. The text also specifies the drug is for prescription-only use.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.